AU533088B2 - Cephalosporins - Google Patents

Cephalosporins

Info

Publication number
AU533088B2
AU533088B2 AU64438/80A AU6443880A AU533088B2 AU 533088 B2 AU533088 B2 AU 533088B2 AU 64438/80 A AU64438/80 A AU 64438/80A AU 6443880 A AU6443880 A AU 6443880A AU 533088 B2 AU533088 B2 AU 533088B2
Authority
AU
Australia
Prior art keywords
salt
see diagramm
hydrate
salts
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU64438/80A
Other versions
AU6443880A (en
Inventor
Marc Montavon
Roland Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU6443880A publication Critical patent/AU6443880A/en
Application granted granted Critical
Publication of AU533088B2 publication Critical patent/AU533088B2/en
Assigned to F. HOFFMANN-LA ROCHE AG reassignment F. HOFFMANN-LA ROCHE AG Alteration of Name(s) in Register under S187 Assignors: F. HOFFMANN-LA ROCHE & CO.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Table Devices Or Equipment (AREA)
  • Laminated Bodies (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Peptides Or Proteins (AREA)

Abstract

For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE 1. A process for the manufacture of acyl derivatives of general formula I see diagramm : EP0030294,P12,F1 in which R represents hydrogen or a readily hydrolyzable ester group, as well as of salts of these compounds and hydrates of these compounds or of their salts by reating a halide of general formula II see diagramm : EP0030294,P12,F2 in which R has the significance given above and Y represents a halogen atom, or a salt of this compound with thiourea and, if desired, converting a compound of formula I obtained into a salt or hydrate or into a hydrate of this salt, characterized in that X signifies one of the groups see diagramm : EP0030294,P13,F3 in which R' represents hydrogen or a readily hydrolysable ether group.
AU64438/80A 1979-11-21 1980-11-17 Cephalosporins Expired AU533088B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1038479 1979-11-21
CH1038479 1979-11-21

Publications (2)

Publication Number Publication Date
AU6443880A AU6443880A (en) 1981-05-28
AU533088B2 true AU533088B2 (en) 1983-10-27

Family

ID=4362652

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64438/80A Expired AU533088B2 (en) 1979-11-21 1980-11-17 Cephalosporins

Country Status (21)

Country Link
EP (1) EP0030294B1 (en)
JP (2) JPS5692894A (en)
KR (1) KR860000852B1 (en)
AT (1) ATE8896T1 (en)
AU (1) AU533088B2 (en)
CA (1) CA1146165A (en)
DE (1) DE3068905D1 (en)
DK (1) DK166728B1 (en)
ES (2) ES8200694A1 (en)
FI (2) FI67385C (en)
GR (1) GR71879B (en)
HU (1) HU184941B (en)
IE (1) IE50516B1 (en)
IL (1) IL61486A (en)
NO (2) NO166229C (en)
NZ (1) NZ195547A (en)
PH (2) PH17359A (en)
PT (1) PT72084B (en)
SI (1) SI8012952A8 (en)
YU (1) YU42364B (en)
ZA (1) ZA807099B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830051B2 (en) * 1986-05-21 1996-03-27 武田薬品工業株式会社 Process for producing 4-halogeno-2-substituted oxyimino-3-oxobutyric acid ester or amide
JP2595605B2 (en) * 1988-01-18 1997-04-02 武田薬品工業株式会社 Method for producing 2-substituted oxyimino-3-oxobutyric acid
AT398764B (en) * 1992-01-28 1995-01-25 Lek Tovarna Farmacevtskih METHOD FOR PRODUCING CEFTRIAXONDINATRIUM SALZHEMIHEPTAHYDRATE
AT399877B (en) * 1992-02-20 1995-08-25 Biochemie Gmbh NEW METHOD FOR PRODUCING CEFTRIAXONE
AT411598B (en) * 1999-04-29 2004-03-25 Biochemie Gmbh Preparation of beta-lactam derivatives used as antibacterial agents by reacting cephalosporanic acid derivative with imine compound, then thiourea compound
AT408225B (en) * 1999-04-29 2001-09-25 Biochemie Gmbh Process for the preparation of cephalosporins
EP1399429A1 (en) * 2001-06-14 2004-03-24 Orchid Chemicals and Pharmaceuticals Ltd 1,3,4-oxadiazol-2-yl thioesters and their use for acylating 7-aminocephalosporins
IN192139B (en) 2001-11-26 2004-02-21 Lupin Ltd
AU2002337437A1 (en) * 2002-04-19 2003-11-03 Orchid Chemicals And Pharmaceuticals Limited A process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
US6919449B2 (en) 2002-04-19 2005-07-19 Orchid Chemicals And Pharmaceuticals Limited Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
US6800756B2 (en) 2002-05-03 2004-10-05 Orchid Chemicals And Pharmaceuticals, Ltd. Method for the preparation of ceftiofur sodium and its intermediates
WO2004083216A1 (en) * 2003-03-20 2004-09-30 Orchid Chemicals & Pharmaceuticals Ltd A process for the preparation of cephalosporins
WO2004092183A2 (en) 2003-04-16 2004-10-28 Sandoz Ag Processes for the preparations of cefepime
US7847093B2 (en) 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
WO2004111059A1 (en) * 2003-06-19 2004-12-23 Orchid Chemicals & Pharmaceuticals Ltd A process for the preparation of a cephalosporin antibiotic
WO2005019227A1 (en) 2003-08-22 2005-03-03 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cephalosporin antibiotic
US20050059820A1 (en) * 2003-09-17 2005-03-17 Debashish Datta Method for manufacture of ceftriaxone sodium
WO2005040175A2 (en) * 2003-10-22 2005-05-06 Ranbaxy Laboratories Limited Process for the preparation of cephem carboxylic acids
US20050119244A1 (en) 2003-12-02 2005-06-02 Acs Dobfar S.P.A. Process for preparing cephalosporins with salified intermediate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200745A (en) * 1977-12-20 1980-04-29 Eli Lilly And Company 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins
JPS5498795A (en) * 1978-01-13 1979-08-03 Takeda Chem Ind Ltd Cephalosporin derivative and its preparation
MC1259A1 (en) * 1978-05-30 1980-01-14 Hoffmann La Roche ACYL DERIVATIVES

Also Published As

Publication number Publication date
NO803516L (en) 1981-05-22
NO166229C (en) 1991-06-19
PH18468A (en) 1985-07-18
SI8012952A8 (en) 1997-06-30
DK496380A (en) 1981-05-22
FI842614A (en) 1984-06-28
EP0030294A3 (en) 1981-12-09
FI67385C (en) 1985-03-11
ZA807099B (en) 1981-11-25
PH17359A (en) 1984-08-01
JPS5692894A (en) 1981-07-27
NO166228B (en) 1991-03-11
HU184941B (en) 1984-11-28
PT72084A (en) 1980-12-01
JPS6145995B2 (en) 1986-10-11
KR860000852B1 (en) 1986-07-09
FI71563C (en) 1987-01-19
FI842614A0 (en) 1984-06-28
FI71563B (en) 1986-10-10
IE50516B1 (en) 1986-04-30
ES503583A0 (en) 1982-06-01
NO812083L (en) 1981-12-22
YU295280A (en) 1983-06-30
PT72084B (en) 1982-07-30
DE3068905D1 (en) 1984-09-13
IL61486A (en) 1984-04-30
GR71879B (en) 1983-08-03
IE802408L (en) 1981-05-21
YU42364B (en) 1988-08-31
FI67385B (en) 1984-11-30
NO166229B (en) 1991-03-11
NZ195547A (en) 1983-05-10
ATE8896T1 (en) 1984-08-15
EP0030294B1 (en) 1984-08-08
JPS61143392A (en) 1986-07-01
ES496994A0 (en) 1981-11-16
ES8200694A1 (en) 1981-11-16
DK166728B1 (en) 1993-07-05
CA1146165A (en) 1983-05-10
ES8204997A1 (en) 1982-06-01
KR830004315A (en) 1983-07-09
EP0030294A2 (en) 1981-06-17
NO166228C (en) 1991-06-19
IL61486A0 (en) 1980-12-31
JPH0248559B2 (en) 1990-10-25
AU6443880A (en) 1981-05-28
FI793768A (en) 1981-05-22

Similar Documents

Publication Publication Date Title
AU533088B2 (en) Cephalosporins
AU537819B2 (en) 2-alkoxyphenyl-imidazo (4,5-b) pyridines
GB2012276A (en) Producing cephalosporins
DE3474148D1 (en) Cephalosporin derivatives and process for their preparation
GR72985B (en)
DE3071315D1 (en) New intermediates for the preparation of cephalosporins and process for the preparation of the intermediates
JPS54160393A (en) Cephem compound having halogenoalkyl group at the 3-position
JPS55115887A (en) 7beta-(4-lower alkylimino-1,3-dithietane-2-yl)carboxamide-3- (1-lower alkyltetrazol-5-yl)thiomethyl-delta3-cephem-4- carboxylic acid

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired